Teneurin c-terminal associated peptides (TCAP) and uses thereof
US8088889B2 · kind B2 · utility
1Cited by
0References
35Claims
0Family size
Inventors
Key dates
| Filing date | May 2, 2003 |
| Grant date | Jan 3, 2012 |
| Priority date | — |
| Expiry date | Jul 28, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/705
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides a novel family of biologically active neuropeptides and the nucleic aid molecules coding for same. The peptides are derived for the C-terminus of the teneurin family peptides (Ten M1-4). These novel peptides, referred to as teneurin C-terminal associated peptides (TCAPs) are active in neuronal communication and are implicated in a number of neuropathologies. They are particularly useful in modulating stress responses and anxiety and in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.